Others

Jeevan Scientific Technology Ltd - Information About The Completion Of USFDA Audit At JSTL Under Regulation 30 Of SEBI (LODR) Regulations, 2015

| Updated on April 24, 2019 Published on April 24, 2019

This is to bring to your kind notice that USFDA conducted an audit of our clinical pharmacology Centre, Hyderabad. The purpose of this audit was to review the BA/BE studies. The auditors started the review on 15th April, 2019 and completed on 24th April, 2019.

We are pleased to inform you that the auditors completed the audit with NIL Observation (i.e. zero 483 observation), signifying that best practices were followed, in compliance to applicable regulations.

Pdf Link: Jeevan Scientific Technology Ltd - Information About The Completion Of USFDA Audit At JSTL Under Regulation 30 Of SEBI (LODR) Regulations, 2015

Source : BSE - www.bseindia.com

Published on April 24, 2019
This article is closed for comments.
Please Email the Editor